NVAX - Novavax Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NVAX (1000694)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m
P1+8+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2023-03-06
NVAXGlenn Gregory MPres, R, DP - Purchase$7.17+6,00018,339+49%+$43,042
2022-03-31
NVAXYoung James FDirS - Sale$73.58-12,50064,090-16%-$919,765
D
2022-01-03
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$140.91-5,0005,592-47%-$704,534
D
2021-12-31
NVAXYoung James FDirS - Sale+OE$144.16-3,75076,590-5%-$540,601
D
2021-12-20
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$230.00-5,0005,592-47%-$1,150,000
D
2021-12-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$174.13-1,6865,663-23%-$293,584
D
2021-12-07
NVAXGlenn Gregory MPres, R, DS - Sale+OE$170.14-8,2504,061-67%-$1,403,631
D
2021-12-01
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$196.19-5,0004,507-53%-$980,944
D
2021-11-30
NVAXGlenn Gregory MPres, R, DS - Sale+OE$203.20-8,9424,061-69%-$1,817,000
D
2021-11-29
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$228.72-5,0004,507-53%-$1,143,600
D
2021-11-26
NVAXGlenn Gregory MPres, R, DS - Sale+OE$218.07-2,0834,753-30%-$454,247
D
2021-11-23
NVAXGlenn Gregory MPres, R, DS - Sale+OE$199.51-8,2504,061-67%-$1,645,914
DM
2021-11-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$169.80-9,4334,061-70%-$1,601,676
D
2021-11-09
NVAXGlenn Gregory MPres, R, DS - Sale+OE$167.54-8,2504,061-67%-$1,382,160
D
2021-11-03
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$200.00-5,0004,507-53%-$1,000,000
D
2021-11-02
NVAXGlenn Gregory MPres, R, DS - Sale+OE$183.82-8,2504,061-67%-$1,516,552
D
2021-11-01
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$163.08-5,0004,507-53%-$815,422
2021-10-29
NVAXGlenn Gregory MPres, R, DS - Sale$148.34-6804,061-14%-$100,871
D
2021-10-26
NVAXGlenn Gregory MPres, R, DS - Sale+OE$132.73-10,3344,741-69%-$1,371,667
D
2021-10-19
NVAXGlenn Gregory MPres, R, DS - Sale+OE$165.14-8,2504,061-67%-$1,362,427
D
2021-10-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$170.00-1,1834,061-23%-$201,110
D
2021-10-12
NVAXGlenn Gregory MPres, R, DS - Sale+OE$163.18-8,2504,061-67%-$1,346,218
D
2021-10-05
NVAXGlenn Gregory MPres, R, DS - Sale+OE$174.41-8,2504,061-67%-$1,438,895
D
2021-10-04
NVAXErck Stanley CPres, CEOS - Sale+OE$176.15-42,82923,879-64%-$7,544,195
D
2021-10-01
NVAXErck Stanley CPres, CEOS - Sale+OE$175.10-49,00023,879-67%-$8,580,064
D
2021-10-01
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$174.89-5,0004,507-53%-$874,452
2021-09-30
NVAXGlenn Gregory MPres, R, DS - Sale$207.25-6934,061-15%-$143,622
D
2021-09-27
NVAXGlenn Gregory MPres, R, DS - Sale+OE$234.43-2,0834,754-30%-$488,315
D
2021-09-28
NVAXTrizzino JohnEVP, CCO, CBOS - Sale+OE$209.92-7,5012,546-75%-$1,574,637
D
2021-09-27
NVAXTrizzino JohnEVP, CCO, CBOS - Sale+OE$234.61-7,5012,546-75%-$1,759,833
2021-09-23
NVAXMott David MDirS - Sale$252.90-24,96140,000-38%-$6,312,616
DM
2021-09-20
NVAXTrizzino JohnEVP, CCO, CBOS - Sale+OE$227.47-15,000718-95%-$3,412,013
D
2021-09-15
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$229.44-5,000706-88%-$1,147,193
D
2021-09-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$229.34-1,1834,061-23%-$271,304
DM
2021-09-13
NVAXTrizzino JohnEVP, CCO, CBOS - Sale+OE$235.95-14,998718-95%-$3,538,794
D
2021-09-01
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$247.97-5,000706-88%-$1,239,867
2021-08-31
NVAXGlenn Gregory MPres, R, DS - Sale$239.87-1,3864,061-25%-$332,463
D
2021-08-26
NVAXGlenn Gregory MPres, R, DS - Sale+OE$233.92-4,1675,447-43%-$974,740
D
2021-08-16
NVAXGlenn Gregory MPres, R, DS - Sale+OE$233.52-1,8664,061-31%-$435,750
D
2021-07-26
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$197.74-2,896706-80%-$572,648
2021-07-20
NVAXGlenn Gregory MPres, R, DS - Sale$215.44-2,4092,811-46%-$518,982
D
2021-07-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$179.45-5,6545,220-52%-$1,014,597
DM
2021-07-01
NVAXErck Stanley CPres, CEOS - Sale+OE$214.38-105,17920,495-84%-$22,548,579
D
2021-06-30
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$212.66-2,896706-80%-$615,848
DM
2021-06-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$189.00-8,1272,811-74%-$1,536,017
2021-06-01
NVAXEvans Gary CDirS - Sale$146.50-62516,099-4%-$91,563
D
2021-05-28
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$149.14-2,895275-91%-$431,748
2021-05-19
NVAXKing Rachel K.DirP - Purchase$139.64+7005,000+16%+$97,748
DM
2021-05-17
NVAXGlenn Gregory MPres, R, DS - Sale+OE$136.39-8,0972,811-74%-$1,104,333
DM
2021-05-05
NVAXTrizzino JohnEVP, CCO, CBO, Interim CFOS - Sale+OE$184.94-3,212287-92%-$594,030
D
2021-04-30
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$239.83-2,895275-91%-$694,317
DM
2021-04-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$206.11-8,1292,811-74%-$1,675,439
DM
2021-04-05
NVAXTrizzino JohnEVP, Chief Commercial OfficerS - Sale+OE$189.38-3,212287-92%-$608,296
D
2021-03-26
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$186.80-2,894275-91%-$540,609
D
2021-03-23
NVAXYoung James FDirS - Sale+OE$228.22-10,00059,000-14%-$2,282,231
2021-03-19
NVAXMcManus Michael A JrDirS - Sale$220.78-4,0005,951-40%-$883,110
D
2021-03-15
NVAXEvans Gary CDirS - Sale+OE$211.21-24,50016,724-59%-$5,174,536
DM
2021-03-15
NVAXGlenn Gregory MPres, R, DS - Sale+OE$204.64-8,1352,811-74%-$1,664,704
DM
2021-03-05
NVAXTrizzino JohnEVP, Chief Commercial OfficerS - Sale+OE$163.74-3,211287-92%-$525,761
D
2021-02-26
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$225.48-2,895275-91%-$652,759
2021-02-18
NVAXGlenn Gregory MPres, R, DS - Sale$269.57-2,4342,811-46%-$656,134
D
2021-02-16
NVAXGlenn Gregory MPres, R, DS - Sale+OE$282.71-5,7125,245-52%-$1,614,812
DM
2021-02-05
NVAXTrizzino JohnEVP, Chief Commercial OfficerS - Sale+OE$292.51-3,216287-92%-$940,719
D
2021-02-01
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$241.50-15,022275-98%-$3,627,789
A
2021-01-25
NVAXTrizzino JohnEVP, Chief Commercial OfficerS - Sale$128.60-73287-20%-$9,388
DM
2021-01-05
NVAXTrizzino JohnEVP, CMO, CBOS - Sale+OE$112.34-17,913287-98%-$2,012,353
D
2020-12-31
NVAXYoung James FDirS - Sale+OE$113.09-11,00011,500-49%-$1,244,015
D
2020-11-16
NVAXErck Stanley CPres, CEOS - Sale+OE$90.65-52,31620,495-72%-$4,742,667
2020-09-30
NVAXTrizzino JohnEVP, CBO, CFOS - Sale$110.22-2,2505,087-31%-$248,002
M
2020-09-30
NVAXErck Stanley CPres, CEOS - Sale$110.23-12,23320,494-37%-$1,348,418
DM
2020-09-28
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$109.04-42,779275-99%-$4,664,546
DM
2020-09-28
NVAXGlenn Gregory MPres, R, DS - Sale+OE$108.84-44,9491,561-97%-$4,892,300
DM
2020-09-28
NVAXTrizzino JohnEVP, CBO, CFOS - Sale+OE$109.03-43,3217,337-86%-$4,723,086
DM
2020-09-28
NVAXErck Stanley CPres, CEOS - Sale+OE$109.95-29,11232,727-47%-$3,200,722
D
2020-08-18
NVAXTrizzino JohnEVP, CBO, CFOS - Sale+OE$148.78-42,7885,087-89%-$6,366,182
D
2020-08-18
NVAXMcManus Michael A JrDirS - Sale+OE$146.00-8,0009,951-45%-$1,168,000
D
2020-08-18
NVAXHerrmann John A IIIEVP, GCS - Sale+OE$144.33-46,242275-99%-$6,673,982
D
2020-08-18
NVAXGlenn Gregory MPres, R, DS - Sale+OE$145.20-55,921311-99%-$8,119,860
D
2020-08-18
NVAXEvans Gary CDirS - Sale+OE$150.44-10,500329,979-3%-$1,579,620
D
2020-06-18
NVAXGlenn Gregory MPres, R, DS - Sale+OE$59.53-16,7491,839-90%-$997,103
2020-06-03
NVAXYoung James FDirP - Purchase$48.83+1,5001,500New+$73,245
D
2020-05-18
NVAXHerrmann John A IIISVP, GCS - Sale+OE$49.44-12,961275-98%-$640,792
2020-01-31
NVAXGlenn Gregory MPres, R, DP - Purchase$3.86+1,2501,373>999%+$4,825
2019-11-18
NVAXMcManus Michael A JrDirS - Sale$3.82-3,9299,951-28%-$15,015
2019-09-17
NVAXHerrmann John A IIISVP, GCS - Sale$7.07-3,6430-100%-$25,757
2019-09-13
NVAXGlenn Gregory MPres, R, DS - Sale$6.18-9,620123-99%-$59,476
2019-09-11
NVAXTrizzino JohnSVP, CBO, CFOS - Sale$5.72-5,5784,800-54%-$31,911
2019-05-13
NVAXGlenn Gregory MPres, R, DP - Purchase$5.85+1,00074,386+1%+$5,850
2019-03-27
NVAXKing Rachel K.DirP - Purchase$0.53+86,00064,000-391%+$45,563
2019-01-31
NVAXGlenn Gregory MPres, R, DP - Purchase$0.88+13,16873,386+22%+$11,588
2018-07-31
NVAXGlenn Gregory MPres, R, DP - Purchase$0.88+13,00760,218+28%+$11,446
2018-05-14
NVAXGlenn Gregory MPres, R, DP - Purchase$1.64+20,00047,211+73%+$32,800
2018-05-14
NVAXTrizzino JohnSVP, CBO, CFOP - Purchase$1.64+50,000138,965+56%+$81,995
2018-05-14
NVAXErck Stanley CPres, CEOP - Purchase$1.65+100,000328,279+44%+$164,620
2018-01-31
NVAXGlenn Gregory MPres, R, DP - Purchase$0.88+12,78427,211+89%+$11,250
2017-11-09
NVAXGlenn Gregory MPres, R, DP - Purchase$1.13+10,00014,427+226%+$11,300
2017-11-09
NVAXErck Stanley CPres, CEOP - Purchase$1.13+100,000228,279+78%+$113,050
2017-08-31
NVAXYoung James FDirS - Sale$1.06-175,0000-100%-$184,870
2017-07-31
NVAXPhillips Barclay ASVP, CFOP - Purchase$0.89+2,05738,669+6%+$1,831
2017-05-12
NVAXMcManus Michael A JrDirP - Purchase$0.97+20,000277,590+8%+$19,396+8

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top